Epidemiology of myocarditis following COVID-19 or influenza and use of diagnostic assessments
These findings support a distinct link between COVID-19 and myocarditis, which appears greater than after a similar viral respiratory infection. As such, a greater degree of clinical suspicion and investigation according to existing diagnostic pathways is recommended.
Authors
- Cornelia Harz
- Oisín Butler (ORCID: https://orcid.org/0000-0001-6462-1664)
- Ann-Kathrin Frenz (ORCID: https://orcid.org/0000-0002-2315-1480)
- Zahra Raisi‐Estabragh (ORCID: https://orcid.org/0000-0002-7757-5465)
- Alexander Michel (ORCID: https://orcid.org/0000-0002-8107-5818)
- Jeanette Schulz‐Menger (ORCID: https://orcid.org/0000-0003-3100-1092)
- Yuchi Han (ORCID: https://orcid.org/0000-0001-7582-1848)
- Jiwon Kim (ORCID: https://orcid.org/0000-0002-8420-8604)
- Sebastian Kelle (ORCID: https://orcid.org/0000-0001-8105-6599)
Institutions
- St Bartholomew's Hospital (GB)
- Queen Mary University of London (GB)
- Cornell University (US)
- Barts Health NHS Trust (GB)
- The Ohio State University Wexner Medical Center (US)
- Deutsches Herzzentrum der Charité (DE)
- Bayer (Switzerland) (CH)
- William Harvey Research Institute (GB)
- Helios Hospital Berlin-Buch (DE)
- Weill Cornell Medicine (US)
- Bayer (Germany) (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Open Heart
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1136/openhrt-2024-002947
- Citations
- 4
- Primary Topic
- Viral Infections and Immunology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- Bayer